KIMBERLY PISARCZYK
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ONEIDA, NY NPI 1578124657
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$1,046.22
- Category: General Payments
- Program years: PY2021–2024
- Record count: 49
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $174.94 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.94 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $51.88 | 2 |
| ABBVIE INC. | $36.60 | 2 |
| Merck Sharp & Dohme Corporation | $34.39 | 2 |
| Exact Sciences Corporation | $19.98 | 1 |
| Novo Nordisk AS | $18.44 | 1 |
| Acerta Pharma LLC | $13.65 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100356312 | Novo Nordisk Inc | $18.44 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104516316 | AstraZeneca Pharmaceuticals LP | $13.65 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108022282 | ABBVIE INC. | $19.99 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1108022284 | ABBVIE INC. | $16.61 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114836853 | Exact Sciences Corporation | $19.98 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133668906 | Gilead Sciences, Inc. | $21.86 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133668908 | Gilead Sciences, Inc. | $30.02 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141843851 | Merck Sharp & Dohme LLC | $17.42 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141919750 | Merck Sharp & Dohme LLC | $16.97 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.